Literature DB >> 34080583

Positive Psychosocial Factors and Oxytocin in the Ovarian Tumor Microenvironment.

Michaela G Cuneo1, Angela Szeto, Andrew Schrepf, Premal H Thaker, Michael Goodheart, Steve W Cole, Anil K Sood, Philip M McCabe, Armando J Mendez, Susan K Lutgendorf.   

Abstract

OBJECTIVE: Clinical ovarian cancer research shows relationships between psychosocial factors and disease-promoting aspects of the stress response (e.g., norepinephrine and cortisol). However, little is known about how psychosocial factors might relate to beneficial hormones in the ovarian tumor microenvironment. Here we examine relationships between psychosocial factors and tumor-associated oxytocin, a hormone linked to survival and antitumor processes in ovarian cancer.
METHODS: Patients with ovarian cancer (n = 96) completed assessments of positive psychosocial factors (social support, positive affect, and purpose in life) and distress (perceived stress and depression) at the time of surgery. Levels of oxytocin and interleukin (IL) 6 in ascites fluid were obtained during surgery and analyzed by enzyme-linked immunosorbent assay. Multiple regression analyses adjusting a priori for patient age and disease stage examined associations between psychosocial factors and ascites oxytocin. IL-6 was used as a covariate in secondary analyses to examine the potentially confounding effects of inflammation in these relationships.
RESULTS: Higher levels of positive affect (β = 0.22, p = .034), purpose in life (β = 0.31, p = .021), and social nurturance (β = 0.24, p = .024) were all related to higher levels of tumor-associated oxytocin at the time of surgery. In contrast, we found no effects for distress or social attachment. Relationships between oxytocin, purpose in life, and social nurturance were independent of IL-6, whereas positive affect was no longer significant with IL-6 in the model.
CONCLUSIONS: Tumor-associated oxytocin may be a previously uninvestigated link in the relationship between psychosocial factors and health in ovarian cancer. Future studies should examine causal mechanisms of relationships observed in this study.
Copyright © 2021 by the American Psychosomatic Society.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34080583      PMCID: PMC8175871          DOI: 10.1097/PSY.0000000000000935

Source DB:  PubMed          Journal:  Psychosom Med        ISSN: 0033-3174            Impact factor:   3.864


  43 in total

1.  Evaluation of enzyme immunoassay and radioimmunoassay methods for the measurement of plasma oxytocin.

Authors:  Angela Szeto; Philip M McCabe; Daniel A Nation; Benjamin A Tabak; Maria A Rossetti; Michael E McCullough; Neil Schneiderman; Armando J Mendez
Journal:  Psychosom Med       Date:  2011-06-02       Impact factor: 4.312

2.  Social influences on clinical outcomes of patients with ovarian cancer.

Authors:  Susan K Lutgendorf; Koen De Geest; David Bender; Amina Ahmed; Michael J Goodheart; Laila Dahmoush; M Bridget Zimmerman; Frank J Penedo; Joseph A Lucci; Parvin Ganjei-Azar; Premal H Thaker; Luis Mendez; David M Lubaroff; George M Slavich; Steven W Cole; Anil K Sood
Journal:  J Clin Oncol       Date:  2012-07-16       Impact factor: 44.544

3.  A global measure of perceived stress.

Authors:  S Cohen; T Kamarck; R Mermelstein
Journal:  J Health Soc Behav       Date:  1983-12

4.  Oxytocin decreases carrageenan induced inflammation in rats.

Authors:  M Petersson; U Wiberg; T Lundeberg; K Uvnäs-Moberg
Journal:  Peptides       Date:  2001-09       Impact factor: 3.750

Review 5.  Psychological well-being revisited: advances in the science and practice of eudaimonia.

Authors:  Carol D Ryff
Journal:  Psychother Psychosom       Date:  2013-11-19       Impact factor: 17.659

Review 6.  From inflammation to sickness and depression: when the immune system subjugates the brain.

Authors:  Robert Dantzer; Jason C O'Connor; Gregory G Freund; Rodney W Johnson; Keith W Kelley
Journal:  Nat Rev Neurosci       Date:  2008-01       Impact factor: 34.870

7.  Epithelial-mesenchymal transition polarization in ovarian carcinomas from patients with high social isolation.

Authors:  Susan K Lutgendorf; Frank Penedo; Michael J Goodheart; Laila Dahmoush; Jesusa M G Arevalo; Premal H Thaker; George M Slavich; Anil K Sood; Steve W Cole
Journal:  Cancer       Date:  2020-07-21       Impact factor: 6.860

8.  Hypothalamic oxytocin mediates social buffering of the stress response.

Authors:  Adam S Smith; Zuoxin Wang
Journal:  Biol Psychiatry       Date:  2013-09-28       Impact factor: 13.382

9.  Genetic manipulation of autonomic nerve fiber innervation and activity and its effect on breast cancer progression.

Authors:  Atsunori Kamiya; Yohsuke Hayama; Shigeki Kato; Akihiko Shimomura; Takushi Shimomura; Katsumasa Irie; Ryosuke Kaneko; Yuchio Yanagawa; Kazuto Kobayashi; Takahiro Ochiya
Journal:  Nat Neurosci       Date:  2019-07-08       Impact factor: 24.884

10.  The pro-social neurohormone oxytocin reverses the actions of the stress hormone cortisol in human ovarian carcinoma cells in vitro.

Authors:  Amanda Mankarious; Foram Dave; George Pados; Dimitris Tsolakidis; Yori Gidron; Yefei Pang; Peter Thomas; Marcia Hall; Emmanouil Karteris
Journal:  Int J Oncol       Date:  2016-03-01       Impact factor: 5.650

View more
  4 in total

Review 1.  Friend and foe: the regulation network of ascites components in ovarian cancer progression.

Authors:  Zhe Geng; Xinxing Pan; Juan Xu; Xuemei Jia
Journal:  J Cell Commun Signal       Date:  2022-10-13       Impact factor: 5.908

Review 2.  Oxytocin and love: Myths, metaphors and mysteries.

Authors:  C Sue Carter
Journal:  Compr Psychoneuroendocrinol       Date:  2021-12-27

Review 3.  Biobehavioral Pathways and Cancer Progression: Insights for Improving Well-Being and Cancer Outcomes.

Authors:  Aeson Chang; Erica K Sloan; Michael H Antoni; Jennifer M Knight; Rachel Telles; Susan K Lutgendorf
Journal:  Integr Cancer Ther       Date:  2022 Jan-Dec       Impact factor: 3.077

Review 4.  Neural Functions of Hypothalamic Oxytocin and its Regulation.

Authors:  Ping Wang; Stephani C Wang; Xiaoyu Liu; Shuwei Jia; Xiaoran Wang; Tong Li; Jiawei Yu; Vladimir Parpura; Yu-Feng Wang
Journal:  ASN Neuro       Date:  2022 Jan-Dec       Impact factor: 5.200

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.